Generating patient-derived clinical metadata and biospecimen samples
Predicting viable biomarkers and therapeutic candidates
Production of small molecules via cell-free expression
High throughput immune-profiling assays
We are using proprietary methods in genomic sequencing, artificial intelligence, and synthetic biology to discover biomarkers and novel therapeutics for the most challenging immunologic disorders.
Dora Yu, PhD
280 Utah Ave. South San Francisco, CA